|
⚲
|
| Keyboard |
| Gerald Cagle | |
|---|---|
| Firm | |
| Address | Fort Worth Club Bldg 306 W 7th Street, Suite 310 Fort Worth, TX 76102 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Nacuity Pharmaceuticals Inc | 021-568281 | Director | 8.4 M of 30.0 M |
||
| Nacuity Pharmaceuticals Inc | 021-394011 | Director | 11.6 M of 17.4 M |
||
| Graybug Vision Inc | 021-263150 | Director | 75.4 M of 80.4 M |
||
| Graybug Inc | 021-253475 | Director | 0.8 M of 1.0 M |
||
| Clearside Biomedical Inc | 021-252601 | Director | 14.4 M of 20.0 M |
||
| Graybug Inc | 021-235354 | Director | 1.7 M of 1.7 M |
||
| Graybug LLC | 021-225918 | Director | 0.8 M of 1.3 M |
||
| Aerie Pharmaceuticals Inc | 021-225197 | Director | 125.0 M of 125.0 M |
||
| Clearside Biomedical Inc | 021-224726 | Director | 16.2 M of 20.0 M |
||
| Cognoptix Inc | 021-216230 | Executive Officer | 0.4 M of 1.5 M |
||
| Aldexa Therapeutics Inc | 021-189330 | Executive Officer | 4.8 M of 8.8 M |
||